Brawn Biotech (BOM:530207) Common Stock: ₹0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530207 Brawn Biotech Ltd BOM:530207
58 GF Score
Price ₹23.00
GF Value ₹21.11
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Brawn Biotech Common Stock?

Brawn Biotech BOM:530207 -0.30% 58 Common Stock is ₹0.0 Mil as of Jun. 2026. GuruFocus rates BOM:530207 with a GF Score™ of 58/100 and a GF Value™ of ₹21.11 (Fairly Valued). The stock has 8 warning signs investors should review.

Brawn Biotech's quarterly common stock increased from Dec. 2025 (₹0.0 Mil) to Mar. 2026 (₹30.0 Mil) but then declined from Mar. 2026 (₹30.0 Mil) to Jun. 2026 (₹0.0 Mil).

Brawn Biotech's annual common stock stayed the same from Mar. 2024 (₹30.0 Mil) to Mar. 2025 (₹30.0 Mil) and stayed the same from Mar. 2025 (₹30.0 Mil) to Mar. 2026 (₹30.0 Mil).

Brawn Biotech Common Stock Historical Data

* Premium members only.

The historical data trend for Brawn Biotech's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Brawn Biotech Common Stock Chart

Brawn Biotech Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.00 30.00 30.00 30.00 30.00

Brawn Biotech Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 30.00 0.00 30.00 0.00
BOM:530207
58GF Score
Brawn Biotech Ltd BOM:530207
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Brawn Biotech Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of ₹0.0 Mil mean?
Brawn Biotech (BOM:530207) has a Common Stock of ₹0.0 Mil as of Jun. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Brawn Biotech and its competitors.
Is Brawn Biotech's Common Stock too high?
Brawn Biotech's current Common Stock is ₹0.0 Mil. Overall, Brawn Biotech has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Brawn Biotech's Common Stock compare to ZTS?
Brawn Biotech's Common Stock of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Brawn Biotech and its competitors. Brawn Biotech's current Common Stock is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Brawn Biotech stock overvalued right now?
Based on GuruFocus' analysis, Brawn Biotech (BOM:530207) is currently considered Fairly Valued. The stock's GF Value™ is ₹21.11, compared to a current price of ₹23.00 — trading 9% above its estimated fair value. The current Common Stock is ₹0.0 Mil. Brawn Biotech's overall GF Score™ is 58/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Brawn Biotech (BOM:530207), the current Common Stock is ₹0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Brawn Biotech (BOM:530207) Overvalued in 2026?

Based on GuruFocus' analysis, Brawn Biotech stock appears to be overvalued. The current stock price of ₹23.00 is trading 9% above its estimated GF Value™ of ₹21.11. GuruFocus considers Brawn Biotech to be Fairly Valued.

Key valuation signals for BOM:530207:

  • Common Stock: ₹0.0 Mil
  • GF Value™: ₹21.11 vs. price of ₹23.00 (9% above fair value)
  • GF Score™: 58/100 with 8 warning signs

No single metric tells the full story. See the BOM:530207 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Brawn Biotech Business Description

Address Lajpat Nagar-1, C-64, First Floor, New Delhi, IND, 110024
Brawn Biotech Ltd is a healthcare company. It is engaged in the business activity of wholesale of pharmaceutical and medical goods. The company's pharmaceutical goods cover product segments like Antibacterial, Cardiovascular, Anti-diabetic, Analgesics, Gastrointestinal, Antifungals, Skin Care, Antipsychotics, Anti-asthmatic, Antacids, Antimalarial, and Nutritionals.
58GF Score

Get the complete analysis for BOM:530207

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹23.00
Price
₹21.11
GF Value